Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar

CompletedOBSERVATIONAL
Enrollment

2,499

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

November 2, 2018

Study Completion Date

November 2, 2018

Conditions
Congestive Heart Failure
Interventions
DEVICE

CRT Therapy - LV Lead Registry

Collecting long-term safety and efficacy data on a market-released left ventricular lead.

Trial Locations (86)

Unknown

Birmingham

Glendale

Mesa

Phoenix

Scottsdale

Tucson

Anaheim

Fairfield

Fountain Valley

Glendale

Hawthorne

Inglewood

Los Angeles

National City

Northridge

Orange

Rancho Mirage

Santa Barbara

Torrance

Ventura

Watsonville

Aurora

Boulder

Danbury

Brooksville

Davenport

Melbourne

Naples

New Smyrna Beach

St. Petersburg

Tampa

Macon

Urbana

Fort Wayne

Valparaiso

Owensboro

Covington

Hammond

Lafayette

Bangor

Baltimore

Cumberland

Lanham

Rockville

Burlington

Worcester

Ann Arbor

Lansing

Lapeer

Saginaw

Wyoming

Ypsilanti

Tupelo

Crystal City

St Louis

Las Vegas

Glen Ridge

New York

Rochester

Gastonia

Winston-Salem

Columbus

Middletown

Steubenville

Toledo

Oklahoma City

Salem

Chinchilla

Lancaster

Philadelphia

Pottstown

Yardley

Columbia

Greenville

Spartanburg

Chattanooga

Amarillo

Brownsville

Corpus Christi

Dallas

Kingwood

McKinney

Nacogdoches

Fredericksburg

Spokane

Yakima

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biotronik, Inc.

INDUSTRY